Evaluation of Nanosuspensions for Absorption Enhancement of Poorly Soluble Drugs: In Vitro Transport Studies Across Intestinal Epithelial Monolayers

Journal Title: The AAPS Journal - Year 2008, Vol 10, Issue 3

Abstract

Budesonide and spironolactone nanosuspensions type DissoCubes® were manufactured by high-pressure piston gap homogenization (Emulsiflex®-C50, Avestin Inc, Ottawa, Canada). Budesonide nanosuspension consisted of 10% budesonide, 5% Octosol 449 (potassium oleate) and 85% water. Spironolactone nanosuspension type DissoCubes® consisted of 10% spironolactone, 0.5% Octowet70 PG (sodium dioctyl sulfosuccinate) and 89.5% water. The mean particle diameters in the nanosuspensions were 581 nm for budesonide and 515 nm for spironolactone, respectively (PCS, Zetasizer 3000 HS Malvern Instruments Ltd, UK).

Authors and Affiliations

T. Lenhardt, G. Vergnault, P. Grenier, D. Scherer, P. Langguth

Keywords

Related Articles

Small Molecule Specific Run Acceptance, Specific Assay Operation, and Chromatographic Run Quality Assessment: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Teams

Consensus practices and regulatory guidance for liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) assays of small molecules are more aligned globally than for any of the other bioanalytical techniques...

Use of FT-NIR transmission spectroscopy for the quantitative analysis of an active ingredient in a translucent pharmaceutical topical gel formulation

The objective of this study was to demonstrate the use of transmission Fourier transform near-infrared (FT-NIR) spectroscopy for quantitative analysis of an active ingredient in a translucent gel formulation. Gels were p...

Influence of P-Glycoprotein Inhibition or Deficiency at the Blood–Brain Barrier on 18F-2-Fluoro-2-Deoxy-d -glucose (18F-FDG) Brain Kinetics

The fluorinated d -glucose analog 18F-2-fluoro-2-deoxy-d -glucose (18F-FDG) is the most prevalent radiopharmaceutical for positron emission tomography (PET) imaging. P-Glycoprotein’s (P-gp, MDR1, and ABCB1) funct...

A Workflow Example of PBPK Modeling to Support Pediatric Research and Development: Case Study with Lorazepam

The use of physiologically based pharmacokinetic (PBPK) models in the field of pediatric drug development has garnered much interest of late due to a recent Food and Drug Administration recommendation. The purpose of thi...

Physical chemical stability of warfarin sodium

Crystalline warfarin sodium is an isopropanol clathrate containing 8.3% isopropyl alcohol (IPA) and 0.57% water upon receipt. The hygroscopicity and impact of moisture on IPA status as well as on the stability of the cla...

Download PDF file
  • EP ID EP681626
  • DOI  10.1208/s12248-008-9050-7
  • Views 76
  • Downloads 0

How To Cite

T. Lenhardt, G. Vergnault, P. Grenier, D. Scherer, P. Langguth (2008). Evaluation of Nanosuspensions for Absorption Enhancement of Poorly Soluble Drugs: In Vitro Transport Studies Across Intestinal Epithelial Monolayers. The AAPS Journal, 10(3), -. https://europub.co.uk/articles/-A-681626